A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia.

Source:http://linkedlifedata.com/resource/pubmed/id/8490166

Blood 1993 May 15 81 10 2496-502

Download in:

View as

General Info

PMID
8490166